Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as needle exchange and opiate substitution therapy (OST) alone. Current HCV treatment is arduous and uptake is low, but new highly effective and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Natasha K, Vickerman, Peter, Grebely, Jason, Hellard, Margaret, Hutchinson, Sharon J, Lima, Viviane D, Foster, Graham R, Dillon, John F, Goldberg, David J, Dore, Gregory J, Hickman, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell publishing Ltd 2013
Materias:
Viral Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933734/
https://www.ncbi.nlm.nih.gov/pubmed/23553643
http://dx.doi.org/10.1002/hep.26431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933734/
https://www.ncbi.nlm.nih.gov/pubmed/23553643
http://dx.doi.org/10.1002/hep.26431

Ejemplares similares